{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:21:36Z","timestamp":1790947296274,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Italian Internal Medicine Society","award":["Mario Condorelli Award"],"award-info":[{"award-number":["Mario Condorelli Award"]}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","award":["EFSD\/Lilly Young Investigator Research"],"award-info":[{"award-number":["EFSD\/Lilly Young Investigator Research"]}],"id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza University of Rome","doi-asserted-by":"crossref","award":["RM1201728887461F"],"award-info":[{"award-number":["RM1201728887461F"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian Ministry of University","award":["2020N5WK98_005"],"award-info":[{"award-number":["2020N5WK98_005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02889-0","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T12:27:29Z","timestamp":1755520049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A decline in renal function is associated with a reduction in myocardial mechano-energetic efficiency in individuals at high cardiometabolic risk"],"prefix":"10.1186","volume":"24","author":[{"given":"Chiara M. A.","family":"Cefalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Vanessa","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velia","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia Chiara","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Succurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"6","key":"2889_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","volume":"95","author":"AA House","year":"2019","unstructured":"House AA, Wanner C, Sarnak MJ, Pi\u00f1a IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA, Conference Participants. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2019;95(6):1304\u201317.","journal-title":"Kidney Int"},{"key":"2889_CR2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1681\/ASN.2006101159","volume":"18","author":"A Kottgen","year":"2007","unstructured":"Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2007;18:1307\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"2889_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","volume":"113","author":"HL Hillege","year":"2006","unstructured":"Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113:671\u20138.","journal-title":"Circulation"},{"key":"2889_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ejhf.821","volume":"19","author":"I Lofman","year":"2017","unstructured":"Lofman I, Szummer K, Dahlstrom U, et al. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Eur J Heart Fail. 2017;19:1606\u201314.","journal-title":"Eur J Heart Fail"},{"key":"2889_CR5","unstructured":"McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley"},{"issue":"3","key":"2889_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","volume":"5","author":"W Gillian","year":"2012","unstructured":"Gillian W, Earle N, Poppe KK, Doughty RN. Meta-analysis global group in chronic heart failure (MAGGIC) investigators renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new chronic kidney disease-epidemiology collaboration group formula. Circ Heart Fail. 2012;5(3):309\u201314.","journal-title":"Circ Heart Fail"},{"key":"2889_CR7","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.3390\/jcm9092681","volume":"9","author":"A Juszczyk","year":"2020","unstructured":"Juszczyk A, Jankowska K, Zawi\u015blak B, Surdacki A, Chyrchel B. Depressed cardiac mechanical energetic efficiency: a contributor to cardiovascular risk in common metabolic diseases-from mechanisms to clinical applications. J Clin Med. 2020;9:2681.","journal-title":"J Clin Med"},{"issue":"7","key":"2889_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/jcm8071044","volume":"8","author":"MA Losi","year":"2019","unstructured":"Losi MA, Izzo R, Mancusi C, et al. Depressed myocardial energetic efficiency increases risk of incident heart failure: the Strong Heart Study. J Clin Med. 2019;8(7):1044.","journal-title":"J Clin Med"},{"key":"2889_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/HJH.0b013e328320ab97","volume":"27","author":"G de Simone","year":"2009","unstructured":"de Simone G, Chinali M, Galderisi M, Benincasa M, Girfoglio D, Botta I, D\u2019Addeo G, de Divitiis O. Myocardial mechano-energetic efficiency in hypertensive adults. J Hypertens. 2009;27:650\u20135.","journal-title":"J Hypertens"},{"issue":"9","key":"2889_CR10","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1097\/HJH.0000000000001007","volume":"34","author":"G de Simone","year":"2016","unstructured":"de Simone G, Izzo R, Losi MA, et al. Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy. J Hypertens. 2016;34(9):1846\u201353.","journal-title":"J Hypertens"},{"issue":"5","key":"2889_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/oby.24006","volume":"32","author":"CMA Cefalo","year":"2024","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, et al. Myocardial mechano-energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity. Obesity. 2024;32(5):888\u201399.","journal-title":"Obesity"},{"issue":"6","key":"2889_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/jhh.2016.88","volume":"31","author":"C Mancusi","year":"2017","unstructured":"Mancusi C, et al. Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients the Campania salute network. J Hum Hypertens. 2017;31(6):395\u20139.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2889_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0862-9","volume":"18","author":"C Mancusi","year":"2019","unstructured":"Mancusi C, et al. Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort. Cardiovasc Diabetol. 2019;18(1): 56.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2889_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12933-021-01248-z","volume":"20","author":"E Succurro","year":"2021","unstructured":"Succurro E, Miceli S, Fiorentino TV, Sciacqua A, Perticone M, Andreozzi F, Sesti G. Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects. Cardiovasc Diabetol. 2021;20(1):60.","journal-title":"Cardiovasc Diabetol"},{"key":"2889_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108883","volume":"177","author":"TV Fiorentino","year":"2021","unstructured":"Fiorentino TV, Miceli S, Succurro E, Sciacqua A, Andreozzi F, Sesti G. Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia. Diabetes Res Clin Pract. 2021;177: 108883.","journal-title":"Diabetes Res Clin Pract"},{"key":"2889_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12933-022-01733-z","volume":"22","author":"E Succurro","year":"2023","unstructured":"Succurro E, Cicone F, Papa A, Miceli S, Vizza P, Fiorentino TV, et al. Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance. Cardiovasc Diabetol. 2023;22:4.","journal-title":"Cardiovasc Diabetol"},{"key":"2889_CR17","doi-asserted-by":"publisher","first-page":"e1264","DOI":"10.1210\/clinem\/dgad300","volume":"108","author":"CMA Cefalo","year":"2023","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Succurro E, Miceli S, Mannino GC, Perticone M, Sciacqua A, Andreozzi F, Sesti G. Metabolic syndrome and C reactive protein are associated with a reduced myocardial mechano-energetic efficiency. J Clin Endocrinol Metab. 2023;108:e1264\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"2889_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejim.2024.09.008","volume":"130","author":"CMA Cefalo","year":"2024","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Succurro E, Perticone M, Sciacqua A, Andreozzi F, Sesti G. Impaired insulin sensitivity measured by estimated glucose disposal rate is associated with decreased myocardial mechano-energetic efficiency in non-diabetic individuals. Eur J Intern Med. 2024;130:144\u201350.","journal-title":"Eur J Intern Med"},{"key":"2889_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/eci.70013","volume":"55","author":"CMA Cefalo","year":"2025","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Succurro E, Perticone M, Cassano V, Sciacqua A, Andreozzi F, Sesti G. The triglyceride glucose (TyG) index is associated with decreased myocardial mechano-energetic efficiency in individuals with different glucose tolerance status. Eur J Clin Invest. 2025;55: e70013.","journal-title":"Eur J Clin Invest"},{"key":"2889_CR20","doi-asserted-by":"publisher","first-page":"110639","DOI":"10.1016\/j.diabres.2023.110639","volume":"199","author":"A Riccio","year":"2023","unstructured":"Riccio A, Mazzanti C, Vero L, Vanessa Fiorentino T, Succurro E, Miceli S, Perticone M, Sciacqua A, Andreozzi F, Cefalo CMA, Sesti G. Association between liver fibrosis and decreased myocardial mechano-energetic efficiency in individuals with different degree of glucose tolerance. Diabetes Res Clin Pract. 2023;199:110639.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2889_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/HJH.0000000000002637","volume":"39","author":"M Salvetti","year":"2021","unstructured":"Salvetti M, Paini A, Bertacchini F, et al. Myocardial mechano-energetic efficiency in primary aldosteronism. J Hypertens. 2021;39(2):318\u201324.","journal-title":"J Hypertens"},{"key":"2889_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12265-023-10441-2","volume":"17","author":"F Borrelli","year":"2024","unstructured":"Borrelli F, Lombardi R, Canciello G, et al. Mechano-energetic efficiency in patients with hypertrophic cardiomyopathy with and without sarcomeric mutations. J Cardiovasc Transl Res. 2024;17:458\u201366.","journal-title":"J Cardiovasc Transl Res"},{"issue":"Suppl. 1","key":"2889_CR23","first-page":"S27","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"Committee ADAPP. Diagnosis and classification of diabetes: standards of care in diabetes\u20142025. Diabetes Care. 2025;48(Suppl. 1):S27\u201349.","journal-title":"Diabetes Care"},{"issue":"4S","key":"2889_CR24","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"7","key":"2889_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"key":"2889_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/01.CIR.0000138745.21879.27","volume":"110","author":"F Perticone","year":"2004","unstructured":"Perticone F, Maio R, Tripepi G, Zoccali C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation. 2004;110:821\u20135.","journal-title":"Circulation"},{"issue":"4","key":"2889_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/01.hjh.0000217839.26971.8d","volume":"24","author":"C Zoccali","year":"2006","unstructured":"Zoccali C. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. J Hypertens. 2006;24(4):611\u20139.","journal-title":"J Hypertens"},{"issue":"5","key":"2889_CR28","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.numecd.2024.01.010","volume":"34","author":"CMA Cefalo","year":"2024","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Massimino M, Mannino GC, Succurro E, Perticone M, Sciacqua A, Andreozzi F, Perticone F, Sesti G. Asymmetric dimethylarginine (ADMA) is associated with reduced myocardial mechano-energetic efficiency in hypertensive subjects. Nutr Metab Cardiovasc Dis. 2024;34(5):1175\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2889_CR29","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s11739-023-03402-9","volume":"18","author":"CMA Cefalo","year":"2023","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Rubino M, Mannino GC, Succurro E, Perticone M, Sciacqua A, Andreozzi F, Sesti G. Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-na\u00efve hypertensive individuals. Intern Emerg Med. 2023;18:2223\u201330.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"2889_CR30","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311(6):F1087\u2013108.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"2889_CR31","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1210\/clinem\/dgac735","volume":"108","author":"A Amouzegar","year":"2023","unstructured":"Amouzegar A, Honarvar M, Masoumi S, Tohidi M, Mehran L, Azizi F. Sex-specific trajectories of insulin resistance markers and reduced renal function during 18 years of follow-up: TLGS. J Clin Endocrinol Metab. 2023;108(6):e230\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2889_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121581","volume":"12","author":"SP Kadatane","year":"2023","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023;12(12): 1581.","journal-title":"Cells"},{"issue":"1","key":"2889_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.ajkd.2020.05.028","volume":"77","author":"SD Navaneethan","year":"2021","unstructured":"Navaneethan SD, Kirwan JP, Remer EM, Schneider E, Addeman B, Arrigain S, Horwitz E, Fink JC, Lash JP, McKenzie CA, Rahman M, Rao PS, Schold JD, Shafi T, Taliercio JJ, Townsend RR, Feldman HI, CRIC Study Investigators. Adiposity, physical function, and their associations with insulin resistance, inflammation, and adipokines in CKD. Am J Kidney Dis. 2021;77(1):44\u201355.","journal-title":"Am J Kidney Dis"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02889-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:47:11Z","timestamp":1757468831000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02889-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02889-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each participant using the principles of the Helsinki Declaration. The study protocol was approved by the Hospital Ethics Review Board (Comitato Etico Azienda Ospedaliera \u201cMater Domini\u201d).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}